Atlas Trials

Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer

Clinical trial NCT00003967 · COMPLETED

Trial details

NCT number
NCT00003967
Sponsor
Gynecologic Oncology Group
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Start date
1999-09-01
Primary completion
2006-04-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.